Would Price Transparency for Generic Drugs Lower Costs for Payers and Patients?

In 2016, retail pharmacies filled over 4.4 billion drug prescriptions, with 4 billion were for low-cost generic drugs, accounting for about $100 billion in drug spending. Steven Lieberman and Paul Ginsburg provide background information on generic prescription drug pricing and outline a proposed policy to generate information on actual average prices paid by retail pharmacies to acquire generic drugs. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

Leave a Reply